The Apixaban Market analysis highlights the growing adoption of Apixaban as an oral anticoagulant for preventing and treating conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Increasing awareness of cardiovascular disorders and the rising prevalence of thromboembolic diseases are driving the market. Apixaban offers advantages over traditional anticoagulants...